Scialini Colombi

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study

Fabio Ciceri, Chiara Bonini, Maria Teresa Lupo Stanghellini et al. · The Lancet Oncology · 2009 · 484 citations

Medicine, Hematology, Immunology +17

Phase I Study of NGR-hTNF, a Selective Vascular Targeting Agent, in Combination with Cisplatin in Refractory Solid Tumors

Vanesa Gregorc, Filippo de Braud, Tommaso Martino De Pas et al. · Clinical Cancer Research · 2011 · 54 citations

Medicine, Oncology, Pharmacology +17

Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma

Armando Santoro, Tiziana Pressiani, Giovanni Citterio et al. · British Journal of Cancer · 2010 · 31 citations · Full text

Medicine, Oncology, Pharmacology +16